Pregled bibliografske jedinice broj: 193920
Classification of Loratadine Based on the Biopharmaceutics Drug Classification Concept and Possible in Vitro - in Vivo Correlation
Classification of Loratadine Based on the Biopharmaceutics Drug Classification Concept and Possible in Vitro - in Vivo Correlation // Biological & pharmaceutical bulletin, 27 (2004), 10; 1630-1635 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 193920 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Classification of Loratadine Based on the Biopharmaceutics Drug Classification Concept and Possible in Vitro - in Vivo Correlation
Autori
Khan, M. Zahirul, I. ; Raušl, Dragica ; Zanoški, Ružica ; Zidar, Snježana ; Horvat Mikulčić, Jasna ; Krizmanić, Lara ; Eškinja, Maja ; Mildner, Boris ; Knežević, Zdravka
Izvornik
Biological & pharmaceutical bulletin (0918-6158) 27
(2004), 10;
1630-1635
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
biopharmaceutics classification system; biorelevant dissolution testing; convolution; permeability testing; in vitro - in vivo correlation; IVIVC; loratadine
Sažetak
Loratadine was studied both in vitro and in vivo (in healthy humans) to classify it according to the Biopharmaceutics Classification System (BSC) in order to gain more understanding of the reasons for its highly variable nature with respect to plasma time profiles, and to determine the most appropriate dissolution test conditions for in vitro assesment of the release profile of the drug from solid dose forms. Based on the solubility of loratadine determined under various pH conditions and its permeability through Caco-2 monolayers, loratadine was classified as a Class II drug. Plasma profiles were predicted by convolution analysis using dissolution profiles obtained under various pH and hydrodynamic conditions as the input function and plasma time data obtained from a syrup formulation as the weighting function. The predicted profiles based on dissolution studies done at gastric pH values were in reasonable agreement with the mean bio-data suggesting dissolution testing should be done at gastric pH values. However, the bio-data were highly variable and it is suggested this may be due, at least in part, to high individual gastric pH variability and dissolution occuring in the intestine on some occasions, and therfore, dissolution testing should also be done in simulated intestinal fluid.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Farmacija
Napomena
Rad nije financiran od strane Ministarstva znanosti republike Hrvatske. Rad je napravljen i fanciran od PLIVA d.d.
POVEZANOST RADA
Profili:
Dragica Lukaček
(autor)
Jasna Horvat-Mikulčić
(autor)
Ružica Zanoški
(autor)
Zdravka Knežević
(autor)
Lara Mikac
(autor)
Boris Mildner
(autor)
Maja Eškinja
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)